Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2002-07-01
|
| Series: | Swiss Medical Weekly |
| Subjects: | |
| Online Access: | https://www.smw.ch/index.php/smw/article/view/197 |
| _version_ | 1811193926791462912 |
|---|---|
| author | S Oertle H Mauron PN Villiger |
| author_facet | S Oertle H Mauron PN Villiger |
| author_sort | S Oertle |
| collection | DOAJ |
| first_indexed | 2024-04-12T00:17:39Z |
| format | Article |
| id | doaj.art-0eaa27246ec449d5a550132c59506000 |
| institution | Directory Open Access Journal |
| issn | 1424-3997 |
| language | English |
| last_indexed | 2024-04-12T00:17:39Z |
| publishDate | 2002-07-01 |
| publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| record_format | Article |
| series | Swiss Medical Weekly |
| spelling | doaj.art-0eaa27246ec449d5a550132c595060002022-12-22T03:55:48ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972002-07-01132293010.4414/smw.2002.10031Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disordersS OertleH MauronPN Villigerhttps://www.smw.ch/index.php/smw/article/view/197etanerceptInfliximabCogan syndromeBehcet's diseaseWegener's diseaserheumatoid arthritis |
| spellingShingle | S Oertle H Mauron PN Villiger Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders Swiss Medical Weekly etanercept Infliximab Cogan syndrome Behcet's disease Wegener's disease rheumatoid arthritis |
| title | Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders |
| title_full | Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders |
| title_fullStr | Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders |
| title_full_unstemmed | Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders |
| title_short | Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders |
| title_sort | inhibition of the tnf pathway use of infliximab and etanercept as remission inducing agents in cases of therapy resistant chronic inflammatory disorders |
| topic | etanercept Infliximab Cogan syndrome Behcet's disease Wegener's disease rheumatoid arthritis |
| url | https://www.smw.ch/index.php/smw/article/view/197 |
| work_keys_str_mv | AT soertle inhibitionofthetnfpathwayuseofinfliximabandetanerceptasremissioninducingagentsincasesoftherapyresistantchronicinflammatorydisorders AT hmauron inhibitionofthetnfpathwayuseofinfliximabandetanerceptasremissioninducingagentsincasesoftherapyresistantchronicinflammatorydisorders AT pnvilliger inhibitionofthetnfpathwayuseofinfliximabandetanerceptasremissioninducingagentsincasesoftherapyresistantchronicinflammatorydisorders |